Background. In the United Kingdom, diabetic nephropathy is a leading cause
of end-stage renal disease. There is a higher incidence amongst subjects of
Indo-Asian and African-Caribbean origin compared with Caucasians that is n
ot wholly explained by the differences in the prevalence of diabetes. There
fore, we postulated that this observation could be related to variations in
the rate of progression of renal disease according to racial origin.
Methods. We conducted a retrospective case-note review of 1684 adult attend
ees of the diabetes clinic. Forty-five patients were found with renal impai
rment (serum creatinine greater than or equal to 170 mu mol/l) due to diabe
tic nephropathy. The patients were of Indo-Asian (n = 10), African-Caribbea
n (n = 11), and Caucasian (n = 24) origin. Progression of nephropathy was a
ssessed by analysing (i) the doubling of serum creatinine through construct
ion of Kaplan-Meier curves and (ii) the slope (beta) of the rate of change
in serum creatinine using linear regression analysis in relation to demogra
phic variables, putative risk factors for nephropathy and antihypertensive
drug therapy.
Results. There were Ilo statistically significant differences between systo
lic and diastolic blood pressure, glycaemic control, smoking habit, baselin
e proteinuria. and usage of angiotensin-converting enzyme inhibitors betwee
n the three groups. The proportion of patients doubling their creatinine wa
s significantly higher in the Indo-Asian compared with the African-Caribbea
n and Caucasian groups (100, 45 and 50%; P = 0.025 respectively). In additi
on, the mean (95% CI) of beta (mu mol/l/month) was highest in the Indo-Asia
n (5.36 (2.21-8.52)) compared with the African-Caribbean (3.14 (0.82-5.46))
and Caucasian (2.22 (1.31-3.14)) groups (P = 0.035). The mean ranks of bet
a were highest in the Indo-Asian group (P = 0.038) after adjusting for marg
inal differences in blood pressure age, gender, baseline proteinuria. anti-
hypertensive treatment, and smoking habit.
Conclusions. In this small cohort of type 2 diabetic subjects with establis
hed renal disease, the rate of decline in renal function is accelerated in
Indo-Asian subjects. This observation could be related to differences in re
noprotection from antihypertensive therapy.